Aleve

Product NDC
0280-6020
11-digit product format
002806020
Labeler code
0280
Product ID
0280-6020_4526be49-a72d-1db7-e063-6394a90a1937
Type
HUMAN OTC DRUG
Nonproprietary name
NAPROXEN SODIUM
Dosage form
TABLET, COATED
Route
ORAL
Labeler
Bayer HealthCare LLC.
Application
NDA020204
Marketing category
NDA
Marketing start
2002-08-01
Substance
NAPROXEN SODIUM
Active strength
220 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage0280-60200280-6020-20DDiscontinued by firm2026-08-11
excluded packagepackage0280-60200280-6020-40DDiscontinued by firm2026-08-11
excluded packagepackage0280-60200280-6020-80DDiscontinued by firm2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Package NDC, Snapshot table
Captured / source datePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-050280-6020-80d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-050280-6020-40d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-050280-6020-20d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-260280-6020-40f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-260280-6020-20f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-260280-6020-80f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-310280-6020-402ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-310280-6020-202ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-310280-6020-802ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-280280-6020-40a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-280280-6020-20a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-280280-6020-80a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-210280-6020-40cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-210280-6020-20cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-210280-6020-80cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-100280-6020-40cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-100280-6020-20cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-100280-6020-80cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-310280-6020-40302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-310280-6020-20302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-310280-6020-80302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-200280-6020-40ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-200280-6020-20ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-200280-6020-80ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100280-6020-400efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-100280-6020-200efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-100280-6020-800efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-080280-6020-80ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-080280-6020-20ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-080280-6020-40ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-030280-6020-80367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-030280-6020-20367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-030280-6020-40367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-090280-6020-80557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-090280-6020-20557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-090280-6020-40557ba5c1ecfa…9c80585c8c6e…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020204-002ALEVENAPROXEN SODIUM220MGTABLET / ORALRLD, RS1994-01-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-1131067a03dcf5…
2025-08-23 18:47 UTC2025-08N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-116a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-1103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-112680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-115bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-1179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-111e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-118072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-115c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-115d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-114b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-1174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-1187673890dc5c…
2021-03-12 10:30 UTC2021-03N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-115aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-118869cabd3fbd…
2020-11-12 02:37 UTC2020-11N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11c0c555d07b60…
2019-12-14 00:12 UTC2019-12N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-113f01610625f2…
2019-09-15 20:21 UTC2019-09N020204-002ALEVEEQ 200MG BASETABLET / ORALRLD, RS1994-01-11b00525d2431f…
2019-07-19 19:46 UTC2019-07N020204-002ALEVEEQ 200MG BASETABLET / ORALRLD, RS1994-01-11ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-116a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-111c564ffb4f44…
2023-12-20 04:57 UTC2023-12N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-119b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-113f0d92c62455…
2023-05-13 08:27 UTC2023-05N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11053a50430f4f…
2023-01-26 05:58 UTC2023-01N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-113bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-113a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N020204-002ALEVE220MGTABLET / ORALRLD, RS1994-01-11cb3db0bc1861…

Additional Listing Data#

Finished product
Yes
Brand name base
Aleve
Brand name suffix
Gelcaps
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
NAPROXEN SODIUM220 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
9TN87S3A3CInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
849574Internal RxNorm lookup
849728Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
0ad8bbb9-dd5f-4273-b085-ee3e5ed22613Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fef6ad89-235f-4274-ba49-a8e53642473eProduct name220250225
594e2c86-3079-4e6e-96c9-48f7a8afc78dProduct name120230718
87fed3e6-8fba-48ef-96b0-3a7fb54b96ffProduct name320230306
b5fdaaec-7251-4da6-9cb2-4e9e76939ec8Product name120200623
e76dbbc1-775d-722c-08ff-ed45e8a80defProduct name320181002
6f4f4521-fd56-1ae6-888b-3b021bd75c7cProduct name120140508
ce67e27d-1d21-5465-4409-b0662dd99d4dProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0280-6020-02AleveGelcaps1 in 1 CARTONTABLET, COATED116
0280-6020-02AleveGelcaps90 in 1 BOTTLETABLET, COATED9016
0280-6020-16AleveGelcaps160 in 1 BOTTLETABLET, COATED16016
0280-6020-20AleveGelcaps20 in 1 BOTTLETABLET, COATED2016
0280-6020-20AleveGelcaps1 in 1 CARTONTABLET, COATED116
0280-6020-40AleveGelcaps40 in 1 BOTTLETABLET, COATED4016
0280-6020-40AleveGelcaps1 in 1 CARTONTABLET, COATED116
0280-6020-80AleveGelcaps80 in 1 BOTTLETABLET, COATED8016
0280-6020-80AleveGelcaps1 in 1 CARTONTABLET, COATED116

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
NAPROXEN SODIUMACTIVE INGREDIENT9TN87S3A3CALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
naproxenACTIVE MOIETY57Y76R9ATQALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O6933ALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86KALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8ALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
GELATININACTIVE INGREDIENT2G86QN327LALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1AALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
POVIDONESINACTIVE INGREDIENTFZ989GH94EALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
TALCINACTIVE INGREDIENT7SEV7J4R1UALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE CONSUMER CARE]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0280-6020ALEVE GELCAPS (NAPROXEN SODIUM) TABLET, COATED [BAYER HEALTHCARE LLC.]15Current NDC, Legacy NDC, 9 package rows20241208_0ad8bbb9-dd5f-4273-b085-ee3e5ed22613.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 21 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Aleve CapletsNAPROXEN SODIUMSelect Consumer Group3ca84972-f8c9-1881-e063-6294a90a90702026-07-03WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204
AleveNAPROXEN SODIUMNavajo Manufacturing Company Inc.590f3be2-20df-4643-9114-e7ed4cf9155c2026-04-08WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204
Aleve CapletsNAPROXEN SODIUMBayer HealthCare LLC.02941928-128a-2c88-e063-6294a90ac6ba2026-03-12WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204
Aleve Headache PainNAPROXEN SODIUMBayer HealthCare LLCc69f4926-c5cd-63a0-e053-2a95a90a2ca62025-12-04WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204
AleveNAPROXEN SODIUMBayer HealthCare LLC.00ef5b30-71d0-4cb4-84a3-48c67d1cea2a2025-12-04Exact identifier
application applno (NDA): 020204
application number: NDA020204
Aleve Back and Muscle PainNAPROXEN SODIUMBayer HealthCare LLC.6376e1b8-52c4-0519-e053-2a91aa0af35f2025-12-04Exact identifier
application applno (NDA): 020204
application number: NDA020204
Aleve CapletsNAPROXEN SODIUMBayer HealthCare LLC.a3745850-3e32-4884-b315-161bcb9996ed2025-12-04Exact identifier
application applno (NDA): 020204
application number: NDA020204
Aleve GelcapsNAPROXEN SODIUMBayer HealthCare LLC.acea54a2-5a92-428e-a778-bb4f9d6767822025-12-04Exact identifier
application applno (NDA): 020204
application number: NDA020204
Aleve GelcapsNAPROXEN SODIUMBayer HealthCare LLC.0ad8bbb9-dd5f-4273-b085-ee3e5ed226132025-12-04WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204
ndc (product): 0280-6020
Aleve Easy Open Arthritis CapNAPROXEN SODIUMBayer HealthCare LLC.3c0ddd25-5a9a-4628-a971-65fe2a9775b52025-12-04WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204
AleveNAPROXEN SODIUMR J General Corporation46e7b298-9e19-49b6-be71-e4fdcb09a5d42025-11-17WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204
Bayer AleveNAPROXEN SODIUMUnifirst First Aid Corporation5dd569ca-d03e-410c-af98-4732c823d5952025-09-09WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204
Aleve Headache PainNAPROXEN SODIUMBayer HealthCare LLC.3ba28e47-1294-bec7-e063-6294a90ac80a2025-08-05WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204
Aleve Caplets - Easy Open Arthritis CapNAPROXEN SODIUMBayer HealthCare LLC.94f09ef7-0695-4499-83c1-95f1e42baf982025-04-10WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204
AleveNAPROXEN SODIUMBayer HealthCare LLC.31bad2d9-c0bb-7f20-e063-6294a90acb172025-04-01WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204
Aleve Back and Muscle PainNAPROXEN SODIUMBayer HealthCare LLC.31bae77b-42dd-94eb-e063-6294a90ad5702025-04-01WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204
Aleve Headache PainNAPROXEN SODIUMBayer HealthCare LLC.31baf777-c805-21ea-e063-6394a90abbd82025-04-01WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204
AleveNAPROXEN SODIUMLil' Drug Store Products, Incabfcf13e-6eba-49e2-8ebf-4593487142702025-01-06WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204
Bayer AleveNAPROXEN SODIUMAcme United Corporationf758201c-28b8-5357-e053-6394a90a1e5d2023-03-20WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204
AleveNAPROXEN SODIUMNavajo Manufacturing Company Inc60637aeb-deb6-4747-e053-2a91aa0ad00b2023-03-01WarningsExact identifier
application applno (NDA): 020204
application number: NDA020204

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
849728Aleve 220 MG Oral TabletPSN0ad8bbb9-dd5f-4273-b085-ee3e5ed2261316
849574naproxen sodium 220 MG Oral TabletPSN0ad8bbb9-dd5f-4273-b085-ee3e5ed2261316
849728naproxen sodium 220 MG Oral Tablet [Aleve]SBD0ad8bbb9-dd5f-4273-b085-ee3e5ed2261316
849574naproxen sodium 220 MG Oral TabletSCD0ad8bbb9-dd5f-4273-b085-ee3e5ed2261316
849728Aleve 220 MG Oral TabletSY0ad8bbb9-dd5f-4273-b085-ee3e5ed2261316
849574naproxen sodium 220 MG (as naproxen 200 MG) Oral TabletSY0ad8bbb9-dd5f-4273-b085-ee3e5ed2261316

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0280-6020-02002806020021 BOTTLE in 1 CARTON (0280-6020-02) / 90 TABLET, COATED in 1 BOTTLE1 bottle2022-10-200000-00-00NoNoCurrent
0280-6020-1600280602016160 TABLET, COATED in 1 BOTTLE (0280-6020-16) 2019-09-260000-00-00NoNoCurrent
0280-6020-200028060202020 in 1 BOTTLEHistorical
0280-6020-400028060204040 in 1 BOTTLEHistorical
0280-6020-800028060208080 in 1 BOTTLEHistorical